Gilead's PrEP Research Deal With CDC Is Factor In Outcome Of HIV Patent Suit

 
• By Brenda Sandburg
  
PrEP on the touch screen with medicine icons on the background blur Doctor in hospital.Innovation treatment, service, data analysis health. Medical Healthcare Concept Pre-Exposure Prophylaxis
Gilead says government patents covering HIV pre-exposure prophylaxis drugs are invalid and unenforceable.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet